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Tetracycline is widely used in the treatment
of acne vulgaris, and several studies have dem-
onstrated significant clinical improvement in
patients on such therapy (1, 2). Yet, why this
drug is helpful in acne is not completely un-
derstood. Small doses do result in a reduction
in the number of bacteria on the skin surface,
(3) as well as in the free fatty acid content
of surface lipids (4). The beneficial effect of
tetracycline may be due to its antibiotic ac-
tion against Coryncbactcrium acncs. Rowever,
the fact that other antibacterial agents, nota-
bly penicillin, which are equally effective
against C. ocnes in vitro (5) do not produce
equal clinical improvement in acne or reduce
the free fatty acid content of skin surface
lipids, leads to consideration of other possible
mechanisms of action of tetracycline in this
condition.
Tetracycline has been demonstrated in the
skin of animals (7, 8) and it has been dem-
onstrated by fluorescence in human hair, nails,
and epitheliomas (9—11). Gould and Ritchie
(12) using microbiological assay methods, re-
ported whole skin levels of tetracycline ap-
proaching 80% of those of the serum. Cullen
and Crounse (13) on the other hand, were not
able to demonstrate, by fluorometry, tetra-
cycline in full thickness biopsies of normal
skin from the buttock, although it was present
in the inflamed skin of patients with der-
matitis or psoriasis.
The present study was undertaken to de-
termine whether tetracycline appears on the
skin surface in significant quantities after oral
administration to normal adults and to pa-
tients with acne.
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MATERiALs AND METHODS
Experimental subjects wore divided into three
groups.
Group I consisted of 5 normal adult volunteers
who took full therapeutic doses (1—1.5 gm, or 14—
19 mgm per kilogram body weight) each day for
14 days.
Group II consisted of 3 normal adults who took
gradually increasing doses of tetracycline up to
full doses, followed by a period of decreasing doses.
Group III consisted of 24 patients with acne
who were taking .250 grams of tetracycline daily
for periods of several weeks or months.
Collection of surfoce film moterial (SFM). Ex-
perimental subjects were requested to avoid ap-
plying cosmetics and rubbing or cleansing their
forehead skin throughout periods of observation.
At approximately mid-afternoon, the surface film
material (SFM) was collected by lightly mbbing
the skin of the forehead area, between the eye-
brows and scalp hairline, with a cotton pledget
moistened with absolute alcohol. This cotton pled-
get was then thoroughly rinsod with several
changes of absolute ethyl alcohol and pressed as
dry as possible. The washing alcohol was then
collected in a previously tared 10 ml glass beaker
and allowed to evaporate to dryness at room tem-
perature, a process which required 24—36 hours.
The quantity of residue SFM was determined by
weighing. The contents of the beaker were then
redissolved in 5 cc of 0.1 N HCI solution and
analyzed for tetracycline content by the spectro-
fluorometric method of Kohn,
Tetracycline levels in freshly drawn aliquots of
serum from the above patients were also deter-
mined by the fluorometric method of Kohn.
Measurements of fluorescence wore made in a
Turner model 110 fluorometer, with filters pro-
viding excitation and emission measurements of
405 and 520 ma respectively. Readings in un-
knowns were compared to those given by freshly
prepared standard solutions of tetracycline and
SFM from individuals not taking the drug. Back-
ground fluorescence corresponding to 0.05 to 0.15
eg tetracycline per 100 mg surface film was re-
corded in surface film from patients not taking
tetracycline.
RESULTS
Group I
Table I shows the levels of tetracycline in sur-
face film of five adults who took full doses of
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TABLE I ured in surface film from 4 to 6 days after dis-
Group I continuing tetracycline therapy. Though levels
of tetracycline varied from day to day, it is seen
that the levels reached bacteriostatic ranges com-
parable to those found in serum. Results from
representative patients are recorded in Graphs
I and II.
Group II patients who took gradually in-
o 76 creasing and decreasing amounts of tetracy-
(012—1.7) dine over a sixteen day period demonstrated
skin levels of tetracycline 5 to 7 days after
1.26 initiating treatment measuring from 0.2 to 1.5
(0.53—1.9) cg per 100 mg. of surface film material. Serum
levels ranged from 0.4 to 4.5 cg per ml. of
0.91 serum. Results from a representative patient
(0.521.4) are recorded in Graph III.
Group III
Group III consisted of patients who had been
taking small doses of tetracycline over a long
period. Skin surface film levels were demon-
strated in 13 out of 23 patients ranging from
.4 to 1.5 p.g per 100 mg. surface film collected.
Serum levels in these patients ranged from .5
to 2.5 cg per ml. Eight patients with dem-
onstrable tetracycline in their sera failed to
Levels of tetracycline in skin surface film from
patients on full therapeutic doses
pg Tetracycline
per 100 mg
surface film
0.58
(0.25—0.89)
Patient
1
2
3
4
5
Daily dose
of
tetracycline(mg/kg.)
17.3
18.9
13.4
17.6
19.1
pg.
Tetracycline
per ml.
serum
1.2
2.5
1.5
1.5
1.4
Group II
0.93
(0.4—1.9)
tetracycline for 14 days. Tetracycline appeared
in surface film 4 to 8 days after starting tetra-
cycline and measured from 0.4 p.g to 1.9 jcg per
100.0 mg. of surface film material. Corresponding
serum levels of tetracycline ranged from 1.4 cg
to 2.5 pg ml. of serum. Tetracycline was meas-
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jig Tetracycline per
100 mg surface film
0.35
1 .85
0.47
1 .73
1 .68
1 .07
1.43
0.48
0.26
0.91
0.63
1.85
1.18
show the drug in their SFM. Two patients
had no demonstrable tetracycline in their sera
at the time the sample was drawn. Results
are shown in Table II.
COMMENT
We have very carefully avoided use of the
term "sehum" in referring to the material re-
moved from the surface of the forehead by
wiping it with alcohol. The surface film ma-
terial probably is composed of a variety of
materials, including sebum, dried sweat, des-
quamating keratin and variable amounts of
extraneous material including Colorado dust
and Denver mud. Thus any measurements of
tetracycline levels in this heterogeneous and
undefined material must not be interpreted as
precise measurements of anything, and it is
not surprising that the measurements indi-
cated wide variation in tetracycline levels
from day to day. We can only conclude that
significant and probably bacteriostatieally ef-
fective quantities of tetracycline do reach the
skin surface film even in patients on small
quantities of this drug.
There is reason to believe that the con-
centrations of tetracycline on the skin surface
are higher than we recorded. There are several
possible reasons why this could be so: 1) the
presence of extraneous material in the weighed
amounts of surface film 2) inadvertent wiping
or washing of the forehead by the patient from
one collection period to another 3) decomposi-
tion of tetracycline on the skin surface and
during the evaporation time required for our
analytical procedure. A better method of col-
lection of tetracycline is in order for more
rapid analysis of the drug. However, when
known amounts of tetracycline were added to
cotton sponges, 80% was recovered by our
analytical methods. We experimented with
other methods of collection, including the cup
method, cigarette paper method, and wiping
the forehead with ether, but found our method
of collection to be superior.
Do the data permit any conclusions about
the route by which tetracycline reaches the
skin surface film? Because of the observed time
lag of 4—8 days between the institution of
therapy and the appearance of measurable
quantities of tetracycline in the skin surface
film, it is tempting to thick that the probable
route is via the sebaeeous glands, which are
known in the rat to have a turnover time of
about this duration (15). The trans-sebaeeous
route also seems attractive because of the
known lipid solubility of tetracycline base in
which form the drug should exist at the
slightly alkaline pH of serum, which would
favor its solubility in the lipid laden seba-
ceous cells.
On the other hand, the delay of several days
in the appearance of measurable quantities of
tetracycline in the skin surface film material
does not completely rule out transepidermal
penetration, or, even more likely, its delivery
by sweat. In these, the reason for the lag period
of several days might be that it takes such a
period for measurable quantities of the drug
to accumulate in the surface film. Actually, it
is quite possible for all three routes, sebaeeous,
transepidermal, or through the sweat glands, to
be operative to greater or lesser degree.
Obviously, a study of this sort raises more
questions than it answers about the phar-
macology of tetracycline in the skin. In par-
TABLE II
Group III
Levels of tetracycline in skin surface film from
patients on prolonged low dosage therapy
Case no.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
Duration of
therapy
2 weeks
S months
4 months
3 months
2 mnnths
3 months
2 months
2 months
2 mnnths
2 months
2 weeks
1 month
1 month
1 month
1 month
3 months
4 months
9 months
2 weeks
8 months
2 weeks
4 months
4 months
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ticular, we have Rot gone as far as we had
hoped in measuring levels of tetracycline at-
tained within the pilosebaceous lumens, in
which acne centers. We have only shown that
tetracycline does attain significant levels on
the skin surface, even after small amounts
have been taken orally, and that there is a lag
period of several days between administration
of the drug and its appearance on the skin
surface.
SUMMARY
Tetracycline was demonstrated in significant
quantities in surface film material collected
from the forehead after oral administration of
tetracycline to normal adults and to patients
with acne. A delay of four to eight days oc-
curred before tetracycline appeared in the sur-
face film material and remained in surface film
material for three to eight days after the drug
was discontinued.
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